EFPIA - NEWSLETTER

EFPIA Newsletter 16 November 2023

World Diabetes Day

Without adequate treatment and management, people with diabetes face significantly reduced quality of life. On World Diabetes Day, EFPIA is happy to support the Diabetes Community's pledge and continue to work together to improve people’s lives.

How would the proposed EU Pharma Legislation affect Europe's competitiveness?

Under the current EU Commission's pharma legislative proposals, Europe risks losing a third of its share of global R&D by 2040, increasing the EU's reliance on other regions for innovation. Discover more here.

iCARE4CVD - A new IHI project

iCARE4CVD is an international, public-private research project that brings together 33 academic and industry partners united in the pursuit of improving the health of patients with CVD. The project will run for 4.5 years, led by University of Maastricht and Novo Nordisk.

Discover more on icare4cvd.eu

Events

24 NOV 2023

Awareness session for SMEs on the reform of the EU pharmaceutical legislation Online

Learn more →

28 NOV 2023

DIA Innovating Clinical Trials in Europe Virtual Event

Must-attend virtual live conference for pharmaceutical innovators and clinical researchers alike.

Learn more →

Forging the Future of Pharma Innovation in Europe - FT Pharma and Biotech Summit

Nathalie Moll, EFPIA Director General, and Jacky Vonderscher, CEO of ENYO Pharma, joined the 2023 FT Global Pharma and Biotech Summit to discuss the opportunities for both big pharma companies and SMEs operating in Europe, considering the upcoming legislative changes.

Watch the event recording.

What we are reading

CEO confidence withers in Europe as regulation weighs down competitiveness 15 November 2023 (ERT)

Focusing in on real-world evidence and its capabilities 14 November 2023 (Pharmaceutical Market Europe)

Elevating innovation through partnerships 26 October 2023 (Politico)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶